MaxCyte, Inc. (MXCT) Tops Q1 EPS by 4c

MaxCyte, Inc. (NASDAQ: MXCT) reported Q1 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $7.3 million.

For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.

You May Also Be Interested In

• Crude Inventory Fell 4.5M Barrels Last Week - EIA
• American Airlines (AAL) call put ratio 1.4 calls to 1 put as share price up 2.2%.
• JetBlue Airways (JBLU) call put ratio 4.8 calls to 1 put with a focus on September 4.5 weekly calls as share price up 4.3%